Bioprocess Automation Software Market Forecast Covering Key Growth Drivers And Future Industry Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Bioprocess Automation Software Market In 2026, And How Will Its Value Evolve By 2030?
The bioprocess automation software market has experienced rapid expansion in recent years. It is projected to increase from $3.07 billion in 2025 to $3.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The growth observed in the past can be attributed to factors such as the increasing demand for biopharmaceutical products, the adoption of automated process control systems, a rising need for process consistency, the expansion of research and development activities, and the growing implementation of laboratory information management systems.
The bioprocess automation software market is poised for significant expansion in the coming years, with its size projected to reach $5.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This anticipated growth throughout the forecast period stems from factors such as the increasing implementation of AI-driven process optimization, greater integration with cloud-based data management, a rising demand for predictive bioprocess monitoring, the development of hybrid automation solutions, and a concerted effort to reduce human error and operational expenditures. Notable trends for this period include the wider adoption of cloud-based bioprocess automation software, a surging need for real-time data analytics in bioprocessing, expanded integration with IoT-enabled bioreactors, the broadening of quality and regulatory compliance automation, and an elevated focus on optimizing upstream and downstream processes.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Major Drivers Are Influencing The Expansion Of The Bioprocess Automation Software Market?
Increased funding allocated to research and development is anticipated to drive the expansion of the bioprocess automation software market moving forward. Research and development involves structured undertakings by businesses and institutions to generate new knowledge, enhance existing offerings, or create innovative technologies and methods. This upsurge in R&D investment is primarily fueled by a rising demand for biologics and advanced therapeutics, as pharmaceutical and biotechnology companies dedicate substantial funds to develop intricate biopharmaceutical products that necessitate sophisticated manufacturing processes. Expanding R&D investment boosts the requirement for bioprocess automation software by demanding advanced digital systems to manage increasingly complex biomanufacturing workflows, ensure regulatory compliance, and optimize production efficiency across both research and commercial operations. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures rose from $892 billion in 2022 to $940 billion in 2023, reflecting an increase of $48 billion. Thus, the growing investment in research and development is propelling the growth of the bioprocess automation software market.
Which Segments Define The Bioprocess Automation Software Market Segment Structure?
The bioprocess automation software market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Type: On Premise, Cloud Based, Hybrid
3) By Enterprise Size: Small And Medium Enterprises, Large Enterprises
4) By Application: Upstream Processing, Downstream Processing, Quality Control, Manufacturing Operations, Data Management, Other Applications
5) By End User: Pharmaceutical Companies, Research Institutes, Contract Manufacturing Organizations, Other End-Users
Subsegments:
1) By Software: Process Automation Software, Data Management Software, Quality Management Software, Regulatory Compliance Software, Analytics And Reporting Software
2) By Services: Implementation Services, Consulting Services, Maintenance And Support Services, Training Services, Managed Services
Which Trends Are Influencing Demand In The Bioprocess Automation Software Market?
Major companies within the bioprocess automation software market are increasingly focusing on forming strategic collaborations to deliver integrated digital solutions that enhance process control, data connectivity, and manufacturing efficiency. Strategic collaborations are structured alliances where organizations work together to pursue common objectives by combining their respective expertise and capabilities. These partnerships help businesses drive innovation, enter new markets, share risks, and strengthen their competitive position without undergoing a merger. For instance, in June 2024, AGU, a Germany-based provider of bioprocess automation technologies, partnered with Genedata, a Switzerland-based bioinformatics software company, to integrate AGU’s SmrtLine Data Cockpit middleware with the Genedata Biopharma Platform. This initiative created a unified bioprocess automation solution designed to automate instrument data capture, streamline data flow in GxP-regulated environments, and aims to improve efficiency and data integrity for biopharma process development.
Who Are The Established Players Within The Bioprocess Automation Software Market?
Major companies operating in the bioprocess automation software market are Honeywell International Inc., Danaher Corporation, Siemens Healthineers AG, Parker Hannifin Corporation, Rockwell Automation Inc., Yokogawa Electric Corporation, Getinge AB, Waters Corporation, Bioengineering AG, Eppendorf SE, Tecan Group Ltd., Repligen Corporation, Hamilton Company, Pierre Guerin SAS, Inscripta Inc., INFORS HT AG, Automated Control Concepts Inc., Synthace Ltd., Flownamics Inc., ILS Automation Inc., and PendoTECH Inc.
Get The Full Bioprocess Automation Software Market Report:
https://www.thebusinessresearchcompany.com/report/bioprocess-automation-software-market-report
Which Region Holds The Highest Market Share In The Bioprocess Automation Software Market?
North America was the largest region in the bioprocess automation software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Bioprocess Automation Software Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Bioprocess Automation Software Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
